nipradilol has been researched along with ng-nitroarginine methyl ester in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (40.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Eto, Y; Honda, K; Natori, K; Nihei, H; Nitta, K; Tsutsui, T; Uchida, K; Yumura, W | 1 |
Gaudette, GR; Horimoto, H; Krukenkamp, IB; Saltman, AE | 1 |
Isenoumi, K; Kitaoka, Y; Kobayashi, S; Kumai, T; Ueno, S | 1 |
Inada, H; Ishimitsu, T; Matsuoka, H; Minami, J; Ono, H | 1 |
Hasuike, Y; Hiraoka, K; Inoue, T; Itahana, R; Izumi, M; Miyagawa, K; Nakanishi, T; Nishihara, F; Takamitsu, Y | 1 |
5 other study(ies) available for nipradilol and ng-nitroarginine methyl ester
Article | Year |
---|---|
Nipradilol inhibits DNA synthesis by regulating nitric oxide synthesis in cultured rat mesangial cells.
Topics: Adrenergic beta-Antagonists; Animals; Cattle; Cells, Cultured; DNA Replication; Enzyme Inhibitors; Glomerular Mesangium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Propanolamines; Rats; Thymidine | 1998 |
Nitric oxide-generating beta-adrenergic blocker nipradilol preserves postischemic cardiac function.
Topics: Action Potentials; Adrenergic beta-Antagonists; Animals; Arginine; Coronary Circulation; Enzyme Inhibitors; Heart; In Vitro Techniques; Ischemic Preconditioning, Myocardial; Male; Myocardial Ischemia; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Propanolamines; Rabbits; Ventricular Pressure | 1999 |
Nipradilol induces vasodilation of canine isolated posterior ciliary artery via stimulation of the guanylyl cyclase-cGMP pathway.
Topics: Adrenergic beta-Antagonists; Animals; Ciliary Arteries; Cyclic GMP; Dogs; Dose-Response Relationship, Drug; Enzyme Inhibitors; Glutathione Transferase; Guanylate Cyclase; In Vitro Techniques; Male; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Norepinephrine; Potassium; Propanolamines; Vasoconstrictor Agents; Vasodilation | 2002 |
Nipradilol prevents L-NAME-exacerbated nephrosclerosis with decreasing of caspase-3 expression in SHR.
Topics: Adrenergic beta-Antagonists; Animals; Apoptosis; Blood Pressure; Caspase 3; Caspases; Hypertension; Male; Nephrosclerosis; NG-Nitroarginine Methyl Ester; Nitric Oxide; Organ Size; Proliferating Cell Nuclear Antigen; Propanolamines; Rats; Rats, Inbred SHR; Rats, Wistar | 2002 |
A nitric oxide-generating beta-blocking agent prevents renal injury in the rat remnant kidney model. Comparative study of two beta-blocking drugs, nipradilol and propranolol.
Topics: Adrenergic beta-Antagonists; Animals; Cyclic GMP; Enzyme Inhibitors; Hypertension; Kidney; Kidney Diseases; Kidney Glomerulus; Male; Nephrectomy; NG-Nitroarginine Methyl Ester; Nitrates; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitrites; Propanolamines; Propranolol; Proteinuria; Rats; Rats, Inbred F344; Renin | 2003 |